EN DE
Watch Holista Colltech Ltd for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Holista Colltech Ltd (HCT) fair value: what the stock is really worth

As of Oct 30, 2026: fair value (intrinsic value) of Holista Colltech Ltd stock A$0.03, price A$0.03, that is 11.1% below the price, quality 34 out of 100. Rating: overvalued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Consumer Defensive AU · ISIN AU000000HCT4

HC Holista Colltech Ltd logo Thin data Nov 10, 2026

Holista Colltech Ltd

HCT · AU
Expensive, weak quality

Our calculation puts a fair price 11% below what the stock costs today.

Low debt
Fair value A$0.0293 · Overvalued
Quality 34/100
Weak Growth (revenue 5y −4.1 %/yr in AUD)
Loss-making · -54.6% net margin (TTM)
Negative free cash flow
Trails peers (0/10)
Narrow moat 11/100 · thin data
Thin data
Estimate⚠ Thinly traded⚠ Small free float
Watch Holista Colltech Ltd for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

A$0.1100 A$0.0050 Fair Value A$0.0293 Aug 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 10, 2026.

How to read this chart

60‑month range A$0.0050 – A$0.1100 · fair‑value band A$0.0276 – A$0.0312 · the A$0.0330 price screens above the A$0.0293 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 10, 2026.

Follow Holista Colltech in your weekly email

Every Wednesday you see whether Holista Colltech is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Holista Colltech Limited operates as a research-driven biotech company in Australia, Malaysia, and the United States. The company operates through Supplements, Ovine Collagen, Infection Control Solutions, Food Ingredients, and Corporate segments.

Show moreShow less

It manufactures and wholesales dietary supplements; cosmetic grade collagen; infection control solutions; and healthy food ingredients, including low-glycemic index (GI) bread, noodles/pasta, and flatbreads, as well as low-calorie/low-GI sugar substitutes.

Further, it offers GI LiTE, a premix glycemic index reducer, and LOGIC, a sweetening solution alternative for health-conscious consumers. The company also offers biogenic particles, low fat chips, and water soluble technology. Holista Colltech Limited is based in Subiaco, Australia.

Stock analysis

Holista Colltech Ltd (HCT) currently trades at A$0.0330, while our estimate is A$0.0293, 11% below the price, so the stock looks overvalued today.

Show more

Valuation

None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Scenario range: A$0.0276 (bear) to A$0.0312 (bull), the price of A$0.0330 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 34/100 (below-average quality), in the Consumer Defensive sector.

Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.

Holista Colltech Ltd reported revenue of A$5.8M in FY2025 versus A$8.0M in FY2021, a compound −7.9%/yr. Reported net income was −A$949K in FY2025.

Key figures

Market cap A$13.2M (≈ $9.1M) Micro · P/S ratio 2.25 · EPS (TTM) A$−0.0100 · Net margin −54.6% · Return on equity −667% · Return on assets (EBIT) −21.3% (5-year average) · Operating margin 2.6% · Revenue (TTM) A$5.9M.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 11 out of 100 (low confidence).

What moves the price

The share trades about 63% below its 52-week high and at its 52-week low, currently below its 200-day average.

For context, the median of 10 Consumer Defensive peers we cover trades at 2% fair-value upside, at −11%, HCT screens richer than that median.

Fair Value

Bear A$0.0276 Fair Value A$0.0293 Bull A$0.0312
Price A$0.0330 · Downside -11.1%
Estimate. None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Quality Score breakdown

Overall quality 34/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 19
How much profit the company makes from its sales and capital
Quality Growth 25
Are margins and returns getting better?
Cashflow 20
Do the profits arrive as real cash?
Financial strength 37
Debt, balance sheet and risk of trouble
Investment 95
Does it invest with discipline instead of growing at any price?
Low Volatility 18
How calm the share price moves, does not count
Price momentum 0
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 0
Distance to the 52-week high, does not count
New shares 36
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 0/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
+3.0%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−11.2%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−4.1%
Start year 2020 (pandemic). Over 10 years: −0.8% a year
Revenue growth 23 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+17.3%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−63.9% (2020) → −14.6% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

HCT screens overvalued: fair value 11% below the price. Compare with Nestlé S.A →

Compare Holista Colltech Ltd with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Packaged Foods · 660 stocks

Beats the industry median on 0/10 measures
Overall it trails its industry peers.
Valuation
Quality Score 34 · Bottom 25%
Fair Value upside −11.2% · Below median
Profitability
Return on assets −16.2% · Bottom 25%
Net margin (12 months) −54.6% · Bottom 25%
Operating margin (12 months) 2.6% · Below median
Growth and dividend
Revenue growth (quarter YoY) 3.6% · Below median
Balance sheet
Debt / equity 0.36× · Highest 25%

Valuation Multiplesvs Packaged Foods median · lower = cheaper

P/B 11.83× · Priciest 25%
P/S (12 months) 2.25× · Priciest 25%
EV/EBITDA 18.4× · Priciest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)18 · sector 34
FUTURE (revenue growth)18 · sector 25
PAST (return on equity)0 · sector 30
HEALTH (low debt)82 · sector 96
DIVIDEND (yield)0 · sector 55

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Packaged Foods stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Wilmar International Limited F34 2.95 SGD 4.93 SGD +67% vs HCT
Inner Mongolia Yili Industrial Group 600887 ¥31.14 ¥41.84 +34% vs HCT
The Kraft Heinz Company KHC $24.24 $29.20 +20% vs HCT
Foshan Haitian Flavouring and Food Company 603288 ¥35.46 ¥39.22 +11% vs HCT
General Mills, Inc GIS $34.60 $35.30 +2% vs HCT
Danone S.A BN €68.32 €50.65 −26% vs HCT
Nestlé S.A NESN CHF 86.41 CHF 59.51 −31% vs HCT
Kerry Group KRZ €97.10 €60.33 −38% vs HCT
Nestlé India Limited NESTLEIND ₹1,298 ₹724.74 −44% vs HCT
Yihai Kerry Arawana Holdings 300999 ¥25.92 ¥12.21 −53% vs HCT

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend StocksUndervalued 52-Week Low StocksStocks for 2027: Large Companies Below Fair Value

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Free calculator Peter Lynch Fair Value Formula &…Free calculator
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Holista Colltech Ltd: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Holista Colltech Ltd Fair Value". https://www.fairvalue-calculator.com/stock/HCT

Frequently asked questions

Is Holista Colltech Ltd (HCT) overvalued or undervalued?
As of Nov 10, 2026, our estimate of fair value is A$0.0293 versus the last price from Oct 30, 2026 of A$0.0330, about 11% lower (overvalued).
What is the fair value of HCT?
Our estimate for Holista Colltech Ltd is A$0.0293 (as of Nov 10, 2026), built from audited fundamentals. Last price (from Oct 30, 2026): A$0.0330.
What is the quality score of HCT?
Holista Colltech Ltd has a Quality Score of 34/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Holista Colltech Ltd (HCT)?
Our calculated price target is the estimate of A$0.0293 (as of Nov 10, 2026). Cautious scenario A$0.0276, optimistic scenario A$0.0312. It is an estimate from revenue and assets compared with similar companies, because none of our valuation models currently carries, not an analyst target.
What is the Holista Colltech Ltd stock forecast for 2026?
Our estimate puts fair value at A$0.0293, about 11% lower versus the last price from Oct 30, 2026 of A$0.0330 (overvalued). Cautious scenario A$0.0276, optimistic scenario A$0.0312. The calculation is refreshed regularly with new filings.
What is the revenue of Holista Colltech Ltd (HCT)?
Holista Colltech Ltd reported trailing-twelve-month revenue of about A$5.9M (latest available figure, as of Nov 10, 2026).
What is the intrinsic value of Holista Colltech Ltd (HCT)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Holista Colltech Ltd it is A$0.0293 per share (as of Nov 10, 2026), against a price of A$0.0330.
Is Holista Colltech Ltd stock overvalued or undervalued in 2026?
As of Nov 10, 2026, HCT trades above its calculated fair value: price A$0.0330, fair value A$0.0293, a gap of about −11% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of HCT?
No. The price is what the market pays today (A$0.0330); the fair value is what the company's own numbers justify (A$0.0293). For Holista Colltech Ltd the two are A$0.0037 per share apart. That gap is exactly why we show both numbers side by side.
How much is Holista Colltech Ltd worth?
The market values Holista Colltech Ltd at about A$13.2M (market capitalisation, as of Nov 10, 2026). Per share that is A$0.0330; our models calculate a fair value of A$0.0293 per share.
What do the bullish and bearish scenarios say about HCT?
Our models span a range for Holista Colltech Ltd: cautious scenario A$0.0276, base A$0.0293, optimistic A$0.0312 per share (as of Nov 10, 2026, price A$0.0330). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Holista Colltech Ltd (HCT)?
Balance-sheet figures for Holista Colltech Ltd (as of Nov 10, 2026): debt of 0.36 per unit of equity. They feed the Quality Score of 34/100, which measures business quality independently of the share price.
How far is HCT from its 52-week high?
Holista Colltech Ltd trades at A$0.0330, about 63% below its 52-week high of A$0.0900 and at the low of A$0.0330 (as of Nov 10, 2026). Distance from the high says nothing about value: that is what the fair value of A$0.0293 is for.
Which stocks are comparable to Holista Colltech Ltd?
From the same area (Consumer Defensive) we also value Nestlé S.A, Danone S.A, Foshan Haitian Flavouring and Food Company, The Kraft Heinz Company, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Holista Colltech Ltd stock attractive at the current price?
The data as of Nov 10, 2026: price A$0.0330, calculated fair value A$0.0293 (−11%), Quality Score 34/100. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
Is it still worth investing in stocks now?
The global stock market currently sits 15.1% above its aggregate fair value. Holista Colltech Ltd itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Holista Colltech Ltd (HCT)?
The latest price we hold is from Oct 30, 2026 and stands at A$0.0330. Our estimate is A$0.0293, about 11% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Holista Colltech Ltd right now?
The price sits above even our optimistic bull case (A$0.0312). The favourable scenario is already priced in. The models converge in a tight band (A$0.0276 to A$0.0312), unusually little disagreement for a valuation. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.

Key figures of Holista Colltech Ltd

How large is the market capitalisation of Holista Colltech Ltd (HCT)?
The market capitalisation of Holista Colltech Ltd is A$13.2M (≈ $9.1M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Holista Colltech Ltd (HCT)?
The price-to-sales ratio of Holista Colltech Ltd is 2.25 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Holista Colltech Ltd (HCT)?
Earnings per share at Holista Colltech Ltd are A$−0.0100. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Holista Colltech Ltd (HCT)?
The net margin of Holista Colltech Ltd is −54.6% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Holista Colltech Ltd (HCT)?
The return on equity (ROE) of Holista Colltech Ltd is −667% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Holista Colltech Ltd (HCT)?
On an EBIT basis the return on assets of Holista Colltech Ltd is −21.3% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Holista Colltech Ltd (HCT)?
The operating margin of Holista Colltech Ltd is 2.6% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Holista Colltech Ltd (HCT)?
Revenue at Holista Colltech Ltd is growing +3.6% versus a year earlier (3y avg −11.2%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Holista Colltech Ltd (HCT) generate?
The free cash flow of Holista Colltech Ltd is −A$1.5M (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does Holista Colltech Ltd (HCT) hold?
Holista Colltech Ltd holds more cash than debt, A$566K net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed

Watch Holista Colltech Ltd in the live analysis

One click puts Holista Colltech Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.